🇺🇸 FDA
Pipeline program

Placebo ADCETRIS ( NaCl 0.9% 100 mL - Injection IV ), ADCETRIS 50 mg powder for concentrate for solution for infusion.

2025-521093-34-00

Phase 3 small_molecule active

Quick answer

Placebo ADCETRIS ( NaCl 0.9% 100 mL - Injection IV ), ADCETRIS 50 mg powder for concentrate for solution for infusion. for rare disease is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
rare disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials